Matters ⌘21
Agenda
11:00 – 11:10am EST
Peter O’Blenis, Chief Executive Officer, Evidence Partners
11:15 – 11:50am EST
Founder & CEO, JMIR Publications
Noon – 12:50pm EST
Industry Best Practices Track Breakouts
Medical Devices
Managing CERs and PERs Programmatically to Meet EU Regulatory Requirements
Maria Fontanazza
Editor-in-Chief, MedTech Intelligence
Dr. Bassil Akra
Founder & CEO, AKRA Team GMBh
Dr. Sara Paquette
PhD, Manager, Medical Writing Medtronic
Dr. David A. Chalyan
Associate Director of Clinical Development – Evidence Transformation,
Philips
Dr. Julien Senac
Global Director – IVD Focus Team, TÜV SÜD
Applying Systematic Reviews to Real-World Evidence Study Design
Dr. Patti Peeples
PhD, Vice President, Evidence & Content, HealthEconomics.com
Michael Broder
President, Partnership for Health Analytic Research (PHAR)
Jesse Ortendahl
Director of Health Economics Partnership for Health Analytic Research (PHAR)
Public Sector
The Importance of Evidence-Based Research for the Public Sector Ecosystem
Katy McFee
Executive Vice-President, Evidence Partners
Dr. Kristina Thayer
Director, Integrated Risk Information System Division, Environmental Protection Agency
Dr. Katya Tsaioun
PhD, Director, Evidence-Based Toxicology Collaboration, Johns Hopkins Bloomberg School of Public Health
Michelle Fleetwood
PhD, Solutions Consultant, Clarivate
1:00 – 1:50pm EST
How Covid-19 Has Shifted Our Understanding and Application of Scientific Evidence
Dr. David Nash, Founding Dean Emeritus, Jefferson College of Population Health is interviewed by Peter O’Blenis, CEO, Evidence Partners
2:00 – 2:50pm EST
Innovation Track Breakouts
Get to the Finish Line Faster and with Less Effort Using Simplified Workflows
Nicole LeDrew
Solution Engineer, Evidence Partners
Automation Can Be Your Best Friend: Streamlining Every Stage of Your Reviews
Ian Stefanison
Chief Technology Officer & ISO in Software Development, Evidence Partners
The Essentials of Transparency Through Automated Tracking
Joanna Lansche
Product Marketing Manager, Evidence Partners
3:00 – 3:15pm EST
Closing Remarks
Peter O’Blenis, Chief Executive Officer, Evidence Partners